side-area-logo

The NuView Board of Directors has deep experience in development and growth of companies in the diagnostic space


Chairman and Chief Executive Officer
Chief Medical Officer, Director
Director
Paul J. Crowe

Chairman and Chief Executive Officer

Mr. Crowe founded NuView Life Sciences in 2005 and serves as its Chairman and Chief Executive Officer.  Mr. Crowe’s experience includes start-up and early-stage healthcare company development, strategic planning, capital formation, M&A, and public offerings.  Mr. Crowe’s career includes senior executive sales and management positions for domestic and multi-national healthcare companies who introduced (a) diagnostic ultrasound in 1973 for Rohe Ultrasound – NV Philips Medical Systems; (b) nuclear magnetic resonance (NMR / MRI) in 1983 for Diasonics NMR Inc.; and (c) mobile positron emission tomography (PET) in 1999 for Mobile P.E.T. Systems Inc., Between 1986 and 1999 Mr. Crowe developed and operated outpatient medical service provider businesses, including diagnostic imaging facilities and gamma knife radio surgery facilities, and currently serves on the Board of Radiosurgical Centers of San Diego located at Scripps Memorial Hospital.

Peter S. Conti, MD, PhD, FACR, FACNP

Chief Medical Officer, Director

Dr. Conti has served as NuView’s chief medical officer and director of the Company since 2005. Dr. Conti is a Professor of Radiology, Pharmaceutical Sciences, and Biomedical Engineering at the University of Southern California as well as the Director of its Positron Imaging Science Center and Clinic. Dr. Conti received a medical degree from Cornell University and completed his residency in Diagnostic Radiology and fellowship in Nuclear Medicine at The Johns Hopkins Medical Institution. He is board-certified in both Diagnostic Radiology and Nuclear Medicine. Dr. Conti currently serves on the Board of Directors and is a past-president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). He also serves on a number of committees for the SNMMI that is focused on the development of the PET technology and its applications in medicine, including those involving government and regulatory affairs. The SNMMI Awards Committee has selected Dr. Conti to be the recipient of the most prestigious peer-reviewed award given by the Society in 2016, the Paul C. Aebersold Award for Outstanding Achievement in Basic Science applied to Nuclear Medicine or Molecular Imaging.

Thomas McCausland

Director

Mr. McCausland joined NuView Life Sciences as a director in October 2007. Over his 40-year career, Mr. McCausland has served in senior executive positions with Westinghouse Electric Corporation and Siemens. From 1997 through 2006, he served as president of the Siemens Medical Customer Solutions Group and during his tenure was instrumental at increasing revenues from $1 billion to over $4 billion. In addition to serving as an advisor to the Radiological Society of North America, the American College of Radiology, and several other healthcare companies, Mr. McCausland also serves as Chairman of the Siemens Foundation, dedicated to improving math and science education in high schools.

Michael Nobel, PhD

Director

Mr. Nobel participated in the introduction of magnetic resonance imaging in 1980 and remained in that field for 26 years. Today he is chairman or board member of seven international companies in diagnostics, treatment, and information systems in the field of medicine. For 15 years Dr. Nobel represented the Nobel family as vice chairman and chairman of its board of directors. He is founder and chairman of the Nobel Sustainability Trust. He is chairman or board member of eight non-for-profit organizations in the field of youth education and development and peace and conflict resolution. Dr. Nobel was visiting professor at the Frontier Research Institute at the Tokyo Institute of Technology between 2007 and 2012. He is currently a senior fellow at the Centre for the Study of World Civilizations at Tokyo Tech and a guest professor at Seisa University. In 2005, he received the Albert Einstein Medal for Outstanding Achievements in Life Sciences and Technology in Jerusalem and in 2006 the International Order of Perfection in Moscow. In 2013, he received the Order of Duty and Honor from the United Nations Council for Public Awards and the Gold Medal from the IINC in Tambov, Russia. The World Federation of Consuls presented him its Order of Merit in 2014. Dr. Nobel obtained a doctorate at the University of Lausanne in psycho-pedagogy.

Mark Godsy

Director

Mr. Godsy is a serial entrepreneur and has extensive experience in corporate development and venture capital.  Mr. Godsy practiced law for five years before entering business and co-founding two successful biotech companies, ID Biomedical Corp. and Angiotech Pharmaceuticals Ltd., both of which became leading Canadian biotechnology firms. Mr. Godsy has been involved in many ventures since he left the his law practice. Mr. Godsy is a graduate of the University of British Columbia and received his law degree from McGill University. Mr. Godsy currently serves as Chairman and CEO of Exro Technologies Inc. and is the founding Chairman of Mojio. Mr. Godsy is a member of the Law Society of British Columbia and is on the Advisory Board for the Faculty of Law at McGill. 

Maury DeWald, CPA

Director

Mr. DeWald has served as the Chairman and CEO of Verity Financial Group, Inc. since 1992, where the primary focus has been in healthcare and technology sectors. He also serves as a director of public companies Healthcare Trust of America, Inc. and Targeted Medical Pharma, Inc. and as a non-executive Chairman of public company Integrated Healthcare Holdings, Inc. Mr. DeWald previously served as a director of Tenet Healthcare Corporation, ARV Assisted Living, Inc., Quality Systems, Inc., and Integrated Healthcare Holdings, Inc. From 1962 to 1991, DeWald was employed by KPMG LLP, where he served at various times as an audit partner, a member of their board of directors, as well as managing partner of the Los Angeles office.